ArticleDiabetologia2021

Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus.

Christina Kohlmorgen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.